What is ANIP's P/E ratio?

ANI PHARMACEUTICALS INC (ANIP) currently trades at a P/E ratio of 20.39.

ANI PHARMACEUTICALS INC reports a Return on Equity (ROE) of 15.95%.

What is ANIP's dividend yield?

ANI PHARMACEUTICALS INC offers a dividend yield of 0.00%.

What is ANIP's Quality Score?

Our AI rates ANIP's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ANIP?

Our AI Timing Score for ANIP is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ANIP belong to?

ANI PHARMACEUTICALS INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange

ANIP (NASDAQ) Stock Analysis | ANI PHARMACEUTICALS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

ANIP AI Analysis Summary

Our AI summary for ANIP: ANI PHARMACEUTICALS INC (NASDAQ), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 20.39, ROE of 15.95%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ANIP

ANI PHARMACEUTICALS INC

USD 79.24

-1.19 (-1.48%) Day Change

Watchlist Portfolio Compare Chart

20.39

P/E

1.09

D/E

16.0%

ROE

6.3%

ROA

0.00%

Div Yield

-0.08

PEG

ANI PHARMACEUTICALS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 79.24 Price -1.19 (-1.48%) Day Change	NEWS SCORE: 99

ANIP, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Quality Factors

47%

In Recommendations?	In "Invest - GROWTH" Section
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	1449
Magic Formula Rank by ROE	1449
Magic Formula Rank by ROIC	1231
Price	79.24
PBV / Sector	3.25 / 3.22
Earning Per Share	3.89

PE / Sector	20.39 / 29.79
PEG or PE/Growth / Sector	-0.08 / 0.13
Average 1M Daily Value	20.69 M GREAT
Average 1W Daily Value	19.80 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	9.71 / 15.21
NPM Average (%) / Sector	0.86 / -10.83
NPM Change Average (%) / Sector	-172.08 / 117.42
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	6.31 / 8.15
ROA Average (%) / Sector	1.22 / 2.87
ROA Change Average (%) / Sector	-190.86 / 112.70
ROE (%) / Sector	15.95 / -1.02
ROE Average (%) / Sector	3.21 / 8.35
ROE Change Average (%) / Sector	-189.86 / 385.91
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.51
Dividend Average (%) / Sector	N/A / 3.06
Dividend Change Average (%) / Sector	N/A / 13.64

Registration Details

Analyze Date	2026-08-01 07:59:28
Symbol	ANIP
Name	ANI PHARMACEUTICALS INC
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NASDAQ
Listed Shares	22.73 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,828.55 / 10,754.62

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 210 Main Street West, Baudette, MN, United States, 56623

Phone: 218 634 3500

Website: https://www.anipharmaceuticals.com

Employees: 970

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.